Merck China Unit Begins Expansion Of Shanghai Production Plant
This article was originally published in PharmAsia News
The China unit of U.S.-based Merck - Merck Sharp & Dohme - began expanding its Shanghai production plant as part of a $162 million expansion plan in the country
You may also be interested in...
Chobani introduces Chobani Probiotic, its first functional probiotics beverage to support digestive and immune health; Danone North America extends its Danimals children’s yogurt line with products to support immune system; and Plexus Worldwide and Sofar Americas roll out children’s probiotics.
Report quantifies social media posts describing adverse events involving the Essure contraceptive device, which was pulled from the market amid safety concerns.
Deal Snapshot: The China/US CAR-T firm will be bought out by its management team and institutional investors in a deal structured as a merger into a new company.